| For: | Shelat VG. Improving clinical outcomes of patients with hepatocellular carcinoma: Role of antiviral therapy, conversion therapy, and palliative therapy. World J Gastrointest Oncol 2024; 16(10): 4037-4041 [PMID: 39473946 DOI: 10.4251/wjgo.v16.i10.4037] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v16/i10/4037.htm |
| Number | Citing Articles |
| 1 |
Vishal G. Shelat. Microbial ecology and hepatocellular carcinoma: should a subset be viewed as a microbiome-conditioned malignancy?. Expert Review of Gastroenterology & Hepatology 2026; doi: 10.1080/17474124.2026.2687711
|
| 2 |
Zhang-you Guo, Mu-yang Tu, Yin-shan Yang, Ling-xiang Xu, Dan-dan Fan. Nomogram for predicting post-transarterial chemoembolization survival in recurrent patients with hepatitis B virus-associated hepatocellular carcinoma. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-26375-5
|